| 000 | 01751 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513155513.0 | ||
| 264 | 0 | _c19990203 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/314551 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuhn, L | |
| 245 | 0 | 0 |
_aDistinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cJan 1999 |
||
| 300 |
_a52-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGestational Age |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aInfant, Premature |
| 650 | 0 | 4 |
_aInfectious Disease Transmission, Vertical _xprevention & control |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications, Infectious _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aZidovudine _xtherapeutic use |
| 700 | 1 | _aSteketee, R W | |
| 700 | 1 | _aWeedon, J | |
| 700 | 1 | _aAbrams, E J | |
| 700 | 1 | _aLambert, G | |
| 700 | 1 | _aBamji, M | |
| 700 | 1 | _aSchoenbaum, E | |
| 700 | 1 | _aFarley, J | |
| 700 | 1 | _aNesheim, S R | |
| 700 | 1 | _aPalumbo, P | |
| 700 | 1 | _aSimonds, R J | |
| 700 | 1 | _aThea, D M | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 179 _gno. 1 _gp. 52-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/314551 _zAvailable from publisher's website |
| 999 |
_c9805001 _d9805001 |
||